FTRE · XBRL financial data

Fortrea Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (FTRE's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Revenue from contracts with customers	775*	662	662	675	697*	651	710	701	661*	637	678	692
Selling, general and administrative	99*	120	156	136	148*	122	125	107	103*	101	102	104
Operating income (loss)	(11)*	(37)	(51)	(18)	(56)*	(520)	(330)	(9)	(14)*	(3)	15	15
Interest expense	35*	—	—	—	—	—	—	—	—	—	—	—
Other income (expense)	2*	1	9	5	6*	0	3	5	0*	1	(0)	0
Income tax expense (benefit)	(5)*	4	11	(17)	(1)*	15	4	(13)	(3)*	11	12	(4)
Net income (loss)	(36)*	(101)	(138)	(28)	(61)*	(563)	(375)	(16)	(33)*	(24)	(13)	1
Earnings per share, basic USD per share	—	(1.13)	(1.55)	(0.31)	(0.68)*	(6.25)	(4.14)	(0.17)	—	(0.25)	(0.14)	0.01
Earnings per share, diluted USD per share	—	(1.13)	(1.55)	(0.31)	(0.68)*	(6.25)	(4.14)	(0.17)	—	(0.25)	(0.14)	0.01
Weighted average shares, basic millions of shares	89*	89	89	90	90*	90	91	91	—	94	95	96
Weighted average shares, diluted millions of shares	89*	89	89	90	90*	90	91	91	—	94	95	101

Fiscal quarters (FTRE's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Cash and cash equivalents	109	93	126	105	119	102	81	131	175	148	169	221
Prepaid and other current assets	92	91	124	143	170	140	140	124	133	114	101	91
Total current assets	1,253	1,200	888	937	948	970	960	919	897	882	924	953
Right-of-use asset	78	—	—	—	66	—	—	—	56	—	—	—
Goodwill	2,029	1,728	1,726	1,767	1,710	1,243	965	958	960	951	950	950
Total assets	4,357	4,240	3,565	3,664	3,579	3,121	2,835	2,742	2,716	2,683	2,715	2,738
Accounts payable	133	131	144	138	138	110	93	50	30	71	54	53
Accrued liabilities	356	329	343	323	370	347	381	370	396	357	381	372
Current portion of long-term debt	26	55	0	0	75	164	75	75	5	11	17	23
Total current liabilities	776	818	749	796	950	999	942	914	913	929	964	983
Long-term debt	1,566	1,559	1,124	1,125	1,050	1,050	1,101	1,052	1,048	1,043	1,037	1,032
Lease liability, non-current	67	60	66	65	61	59	53	52	54	56	54	54
Total liabilities	2,618	2,648	2,104	2,150	2,217	2,262	2,246	2,161	2,152	2,158	2,191	2,206
Accumulated deficit	(49)	(170)	(308)	(336)	(397)	(960)	(1,335)	(1,351)	(1,383)	(1,407)	(1,420)	(1,419)
Total stockholders' equity	1,739	1,592	1,461	1,514	1,362	859	589	581	564	526	524	532
Total liabilities and equity	4,357	4,240	3,565	3,664	3,579	3,121	2,835	2,742	2,716	2,683	2,715	2,738
Common shares outstanding (cover page) millions of shares	89	89	90	90	90	91	91	92	94	≈95	95	97

≈ Rounded on cover: the filing states this count rounded, and it sits more than 1% off the weighted shares for the period.

Fiscal quarters (FTRE's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Net income (loss)	(36)*	(101)	(138)	(28)	(61)*	(563)	(375)	(16)	(33)*	(24)	(13)	1
Stock-based compensation	16*	15	15*	13*	15*	15	23*	22*	15*	11	13*	12*
Depreciation and amortization	24*	24	21*	21*	21*	20	20*	20*	19*	20	20*	20*
Net cash from operating activities	12*	(26)	274*	(2)*	17*	(124)	22*	87*	129*	(17)	29*	61*
Net cash from investing activities	(9)*	(9)	265*	(8)*	4*	16	(8)*	13*	(8)*	(8)	(7)*	(8)*
Repayments of long-term debt	8*	8	475*	0*	0*	0	0*	0*	76*	—	—	—
Net cash from financing activities	(5)*	21	(504)*	(14)*	(1)*	88	(39)*	(50)*	(76)*	0	0*	0*
Net change in cash	1*	(16)	33*	(21)*	13*	(17)	(20)*	50*	43*	(27)	21*	52*

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Fortrea Holdings	221	692	61*	96.5M	—	Q3 FY26 10-QSep 30, 2026
Celcuity	182	not reported	(55)*	48.9M	13.6 quarters	Q2 FY26 10-QJun 30, 2026
Castle Biosciences	62	104	15*	30.5M	—	Q2 FY26 10-QJun 30, 2026
Personalis	94	22	(26)*	106.8M	8.3 quarters	Q2 FY26 10-QJun 30, 2026
Fulgent Genetics	26	85	(24)*	27.5M	10.8 quarters	Q2 FY26 10-QJun 30, 2026
CareDx	250	139	13*	52.5M	—	Q3 FY26 10-QSep 30, 2026
Lumexa Imaging Holdings	70	264	33*	96.1M	—	Q2 FY26 10-QJun 30, 2026
Exagen	25	20	4*	24.2M	—	Q2 FY26 10-QJun 30, 2026
Veracyte	300	150	46*	80.4M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.